Alcon Inc. (NYSE: ALC) Stock Competitors & Peer Comparison

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, STE has a market cap of 24.6B. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while STE trades at $252.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas STE's P/E ratio is 24.21. In terms of profitability, ALC's ROE is +0.03%, compared to STE's ROE of +0.11%. Regarding short-term risk, ALC is less volatile compared to STE. This indicates lower risk in terms of short-term price fluctuations for ALC.Check STE's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, QDEL has a market cap of 731.8M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while QDEL trades at $10.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas QDEL's P/E ratio is 7.96. In terms of profitability, ALC's ROE is +0.03%, compared to QDEL's ROE of -0.20%. Regarding short-term risk, ALC is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for ALC.Check QDEL's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, MLAB has a market cap of 717.7M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while MLAB trades at $128.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas MLAB's P/E ratio is 12.94. In terms of profitability, ALC's ROE is +0.03%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, ALC is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for ALC.Check MLAB's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, BWAY has a market cap of 437.7M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while BWAY trades at $11.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas BWAY's P/E ratio is 28.35. In terms of profitability, ALC's ROE is +0.03%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, ALC is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for ALC.Check BWAY's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, MASS has a market cap of 435.9M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while MASS trades at $10.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas MASS's P/E ratio is -17.57. In terms of profitability, ALC's ROE is +0.03%, compared to MASS's ROE of -0.25%. Regarding short-term risk, ALC is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for ALC.Check MASS's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, SI has a market cap of 425.1M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while SI trades at $20.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas SI's P/E ratio is -11.80. In terms of profitability, ALC's ROE is +0.03%, compared to SI's ROE of -0.26%. Regarding short-term risk, ALC is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for ALC.Check SI's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, MOBI has a market cap of 372.9M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while MOBI trades at $11.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas MOBI's P/E ratio is -3.78. In terms of profitability, ALC's ROE is +0.03%, compared to MOBI's ROE of -22.21%. Regarding short-term risk, ALC is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for ALC.Check MOBI's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, LAB has a market cap of 252.5M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while LAB trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas LAB's P/E ratio is -9.14. In terms of profitability, ALC's ROE is +0.03%, compared to LAB's ROE of -0.08%. Regarding short-term risk, ALC is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for ALC.Check LAB's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, ANIK has a market cap of 194.9M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while ANIK trades at $14.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas ANIK's P/E ratio is 29.71. In terms of profitability, ALC's ROE is +0.03%, compared to ANIK's ROE of -0.01%. Regarding short-term risk, ALC is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for ALC.Check ANIK's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while EDAP trades at $4.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas EDAP's P/E ratio is -5.80. In terms of profitability, ALC's ROE is +0.03%, compared to EDAP's ROE of -2.41%. Regarding short-term risk, ALC is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for ALC.Check EDAP's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, APYX has a market cap of 123.4M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while APYX trades at $2.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas APYX's P/E ratio is -14.65. In terms of profitability, ALC's ROE is +0.03%, compared to APYX's ROE of -0.71%. Regarding short-term risk, ALC is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for ALC.Check APYX's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, TRIB has a market cap of 112M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while TRIB trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas TRIB's P/E ratio is -0.09. In terms of profitability, ALC's ROE is +0.03%, compared to TRIB's ROE of +0.49%. Regarding short-term risk, ALC is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for ALC.Check TRIB's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, SKIN has a market cap of 102.2M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while SKIN trades at $15.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas SKIN's P/E ratio is -71.41. In terms of profitability, ALC's ROE is +0.03%, compared to SKIN's ROE of -0.32%. Regarding short-term risk, ALC is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for ALC.Check SKIN's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, NYXH has a market cap of 84.4M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while NYXH trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas NYXH's P/E ratio is -0.33. In terms of profitability, ALC's ROE is +0.03%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, ALC is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for ALC.Check NYXH's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, MDAI has a market cap of 48.9M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while MDAI trades at $1.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas MDAI's P/E ratio is -3.38. In terms of profitability, ALC's ROE is +0.03%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, ALC is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for ALC.Check MDAI's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, BEAT has a market cap of 22.9M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while BEAT trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas BEAT's P/E ratio is -0.80. In terms of profitability, ALC's ROE is +0.03%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, ALC is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for ALC.Check BEAT's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, DRIO has a market cap of 22.5M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while DRIO trades at $2.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas DRIO's P/E ratio is -0.39. In terms of profitability, ALC's ROE is +0.03%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, ALC is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for ALC.Check DRIO's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, MDAIW has a market cap of 13.7M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while MDAIW trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas MDAIW's P/E ratio is -1.21. In terms of profitability, ALC's ROE is +0.03%, compared to MDAIW's ROE of N/A. Regarding short-term risk, ALC is less volatile compared to MDAIW. This indicates lower risk in terms of short-term price fluctuations for ALC.Check MDAIW's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, ITOC has a market cap of 11.8M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while ITOC trades at $1.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas ITOC's P/E ratio is -0.41. In terms of profitability, ALC's ROE is +0.03%, compared to ITOC's ROE of -0.60%. Regarding short-term risk, ALC is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for ALC.Check ITOC's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, BEATW has a market cap of 6.1M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while BEATW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas BEATW's P/E ratio is -0.02. In terms of profitability, ALC's ROE is +0.03%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, ALC is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for ALC.Check BEATW's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while QTEXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, ALC's ROE is +0.03%, compared to QTEXW's ROE of N/A. Regarding short-term risk, ALC is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for ALC.Check QTEXW's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, WOK has a market cap of 2.3M. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while WOK trades at $0.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas WOK's P/E ratio is N/A. In terms of profitability, ALC's ROE is +0.03%, compared to WOK's ROE of -0.19%. Regarding short-term risk, ALC is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for ALC.Check WOK's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, FEED has a market cap of 951.4K. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while FEED trades at $1.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas FEED's P/E ratio is -0.15. In terms of profitability, ALC's ROE is +0.03%, compared to FEED's ROE of -0.60%. Regarding short-term risk, ALC is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for ALC.Check FEED's competition here

Alcon Inc. (NYSE: ALC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALC stands at 36.2B. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, ALC is priced at $74.94 on the NYSE, while TIVC trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALC currently has a P/E ratio of 23.56, whereas TIVC's P/E ratio is -0.04. In terms of profitability, ALC's ROE is +0.03%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, ALC is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for ALC.Check TIVC's competition here